Literature DB >> 12634862

Familial juvenile hyperuricaemic nephropathy (FJHN): linkage analysis in 15 families, physical and transcriptional characterisation of the FJHN critical region on chromosome 16p11.2 and the analysis of seven candidate genes.

Blanka Stibůrková1, Jacek Majewski, Katerina Hodanová, Lenka Ondrová, Markéta Jerábková, Marie Zikánová, Petr Vylet'al, Ivan Sebesta, Anthony Marinaki, Anne Simmonds, Gert Matthijs, Jean-Pierre Fryns, Rosa Torres, Juan García Puig, Jurg Ott, Stanislav Kmoch.   

Abstract

Familial juvenile hyperuricaemic nephropathy (FJHN) is an autosomal dominant renal disease characterised by juvenile onset of hyperuricaemia, gouty arthritis, and progressive renal failure at an early age. Recent studies in four kindreds showed linkage of a gene for FJHN to the same genomic interval on chromosome 16p11.2, where the gene for the phenotypically similar medullary cystic disease type 2 (MCKD2) has been localised. In this study we performed linkage analysis in additional 15 FJHN families. Linkage of FJHN to 16p11.2 was confirmed in six families, which suggests that, in a large proportion of FJHN kindreds, the disease is likely to be caused by a gene or genes located outside of 16p11.2. Haplotype analysis of the new and previously analysed families provided two non-overlapping critical regions on 16p11.2-FJHN1, delimited by markers D16S499-D16S3036 and FJHN2, delimited by markers D16S412-D16S3116. Considering MCKD2 to be a distinct molecular entity, the analysis suggests that as many as three kidney disease genes may be located in close proximity on 16p11.2. From genomic databases we compiled integrated physical and transcription maps of whole critical genomic region in which 45 known genes and 129 predicted loci have been localised. We selected, analysed and found no pathogenic mutations in seven candidate genes. The linkage and haplotype analysis reported here demonstrates the genetic heterogeneity of FJHN. The report of integrated physical and mostly in-silico predicted transcription maps of the FJHN critical region provides a basis for precise experimental annotation of the current transcript map, which is essential for final identification of the FJHN gene(s).

Entities:  

Mesh:

Year:  2003        PMID: 12634862     DOI: 10.1038/sj.ejhg.5200937

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  2 in total

1.  Heterozygous Loss-of-Function SEC61A1 Mutations Cause Autosomal-Dominant Tubulo-Interstitial and Glomerulocystic Kidney Disease with Anemia.

Authors:  Nikhita Ajit Bolar; Christelle Golzio; Martina Živná; Gaëlle Hayot; Christine Van Hemelrijk; Dorien Schepers; Geert Vandeweyer; Alexander Hoischen; Jeroen R Huyghe; Ann Raes; Erve Matthys; Emiel Sys; Myriam Azou; Marie-Claire Gubler; Marleen Praet; Guy Van Camp; Kelsey McFadden; Igor Pediaditakis; Anna Přistoupilová; Kateřina Hodaňová; Petr Vyleťal; Hana Hartmannová; Viktor Stránecký; Helena Hůlková; Veronika Barešová; Ivana Jedličková; Jana Sovová; Aleš Hnízda; Kendrah Kidd; Anthony J Bleyer; Richard S Spong; Johan Vande Walle; Geert Mortier; Han Brunner; Lut Van Laer; Stanislav Kmoch; Nicholas Katsanis; Bart L Loeys
Journal:  Am J Hum Genet       Date:  2016-07-07       Impact factor: 11.025

2.  Whole genome sequence analysis identifies a PAX2 mutation to establish a correct diagnosis for a syndromic form of hyperuricemia.

Authors:  Mark Stevenson; Alistair T Pagnamenta; Silvia Reichart; Charlotte Philpott; Kate E Lines; Caroline M Gorvin; Karl Lhotta; Jenny C Taylor; Rajesh V Thakker
Journal:  Am J Med Genet A       Date:  2020-08-09       Impact factor: 2.578

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.